ID   RFFL_RAT                Reviewed;         362 AA.
AC   Q8CIN9; Q6AY29;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   02-OCT-2024, entry version 146.
DE   RecName: Full=E3 ubiquitin-protein ligase rififylin;
DE            EC=2.3.2.27 {ECO:0000250|UniProtKB:Q8WZ73};
DE   AltName: Full=FYVE-RING finger protein Sakura {ECO:0000303|PubMed:12859687};
DE   AltName: Full=RING finger and FYVE-like domain-containing protein 1;
DE   AltName: Full=RING-type E3 ubiquitin transferase rififylin {ECO:0000305};
GN   Name=Rffl {ECO:0000312|RGD:727916};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, UBIQUITINATION,
RP   SUBCELLULAR LOCATION, PALMITOYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Hippocampus;
RX   PubMed=12859687; DOI=10.1046/j.1471-4159.2003.01875.x;
RA   Araki K., Kawamura M., Suzuki T., Matsuda N., Kanbe D., Ishii K.,
RA   Ichikawa T., Kumanishi T., Chiba T., Tanaka K., Nawa H.;
RT   "A palmitoylated RING finger ubiquitin ligase and its homologue in the
RT   brain membranes.";
RL   J. Neurochem. 86:749-762(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225; SER-228 AND SER-239, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that regulates several biological
CC       processes through the ubiquitin-mediated proteasomal degradation of
CC       various target proteins. Mediates 'Lys-48'-linked polyubiquitination of
CC       PRR5L and its subsequent proteasomal degradation thereby indirectly
CC       regulating cell migration through the mTORC2 complex. Also
CC       ubiquitinates the caspases CASP8 and CASP10, promoting their
CC       proteasomal degradation, to negatively regulate apoptosis downstream of
CC       death domain receptors. Also negatively regulates the tumor necrosis
CC       factor-mediated signaling pathway through targeting of RIPK1 to
CC       ubiquitin-mediated proteasomal degradation. Negatively regulates
CC       p53/TP53 through its direct ubiquitination and targeting to proteasomal
CC       degradation. Indirectly, may also negatively regulate p53/TP53 through
CC       ubiquitination and degradation of SFN. May also play a role in
CC       endocytic recycling. {ECO:0000269|PubMed:12859687}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000250|UniProtKB:Q8WZ73};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q8WZ73}.
CC   -!- SUBUNIT: Interacts with CASP8 and CASP10. Interacts with RIPK1 (via
CC       protein kinase domain); involved in RIPK1 ubiquitination. Interacts
CC       with PRR5L. Interacts (via RING-type zinc finger) with p53/TP53;
CC       involved in p53/TP53 ubiquitination. Interacts (via RING-type zinc
CC       finger) with MDM2; the interaction stabilizes MDM2.
CC       {ECO:0000250|UniProtKB:Q8WZ73}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12859687}.
CC       Cell membrane {ECO:0000269|PubMed:12859687}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:12859687}. Recycling endosome membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=The
CC       FYVE-type zinc finger may mediate phosphatidylinositol phosphate-
CC       binding and control subcellular localization.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8CIN9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8CIN9-2; Sequence=VSP_015757;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Detected in cerebrum, cerebellum,
CC       midbrain, brain stem, hippocampus, striatum, liver, heart, lung,
CC       kidney, muscle, spleen and testis. {ECO:0000269|PubMed:12859687}.
CC   -!- DOMAIN: The RING-type zinc finger is required for the ubiquitination of
CC       target proteins. {ECO:0000250|UniProtKB:Q8WZ73}.
CC   -!- DOMAIN: The FYVE-type zinc finger domain is required for localization
CC       to the recycling endosome membranes and the function in endocytic
CC       recycling. {ECO:0000250|UniProtKB:Q6ZQM0}.
CC   -!- PTM: Autoubiquitinated. {ECO:0000305|PubMed:12859687}.
CC   -!- PTM: Palmitoylated. {ECO:0000269|PubMed:12859687}.
CC   -!- PTM: Undergoes caspase-mediated cleavage upon death-receptor
CC       activation, by TNFSF10 for instance. May be mediated by the caspases
CC       CASP8 and CASP10 in a negative feedback loop (By similarity).
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY157969; AAN60074.1; -; mRNA.
DR   EMBL; BC079216; AAH79216.1; -; mRNA.
DR   RefSeq; NP_001004068.1; NM_001004068.1. [Q8CIN9-2]
DR   RefSeq; XP_006247040.1; XM_006246978.3.
DR   RefSeq; XP_006247041.1; XM_006246979.3.
DR   AlphaFoldDB; Q8CIN9; -.
DR   SMR; Q8CIN9; -.
DR   STRING; 10116.ENSRNOP00000067950; -.
DR   iPTMnet; Q8CIN9; -.
DR   PhosphoSitePlus; Q8CIN9; -.
DR   PaxDb; 10116-ENSRNOP00000045245; -.
DR   Ensembl; ENSRNOT00000076598.3; ENSRNOP00000067950.1; ENSRNOG00000007596.9. [Q8CIN9-2]
DR   GeneID; 282844; -.
DR   KEGG; rno:282844; -.
DR   AGR; RGD:727916; -.
DR   CTD; 117584; -.
DR   RGD; 727916; Rffl.
DR   VEuPathDB; HostDB:ENSRNOG00000007596; -.
DR   eggNOG; KOG4275; Eukaryota.
DR   GeneTree; ENSGT00390000012719; -.
DR   InParanoid; Q8CIN9; -.
DR   OrthoDB; 383715at2759; -.
DR   PhylomeDB; Q8CIN9; -.
DR   Reactome; R-RNO-6804757; Regulation of TP53 Degradation.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q8CIN9; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000007596; Expressed in testis and 19 other cell types or tissues.
DR   ExpressionAtlas; Q8CIN9; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0010008; C:endosome membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002039; F:p53 binding; ISO:RGD.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006886; P:intracellular protein transport; ISO:RGD.
DR   GO; GO:2001271; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; ISS:UniProtKB.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISS:UniProtKB.
DR   GO; GO:1901797; P:negative regulation of signal transduction by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0010762; P:regulation of fibroblast migration; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   CDD; cd15770; FYVE_CARP2; 1.
DR   CDD; cd16707; RING-HC_CARP2; 1.
DR   Gene3D; 1.10.720.140; -; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR049320; CARP1_2_FYVE.
DR   InterPro; IPR049322; CARP2_FYVE.
DR   InterPro; IPR051728; RING-FYVE_E3_ubiquitin-ligase.
DR   InterPro; IPR036361; SAP_dom_sf.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR14879; CASPASE REGULATOR, RING FINGER DOMAIN-CONTAINING; 1.
DR   PANTHER; PTHR14879:SF2; E3 UBIQUITIN-PROTEIN LIGASE RIFIFYLIN; 1.
DR   Pfam; PF21272; FYVE_CARP1-2; 1.
DR   Pfam; PF22968; RNF34L-like_3rd; 1.
DR   Pfam; PF13920; zf-C3HC4_3; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57903; FYVE/PHD zinc finger; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF68906; SAP domain; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Cell membrane; Cytoplasm; Endosome;
KW   Lipoprotein; Membrane; Metal-binding; Palmitate; Phosphoprotein;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..362
FT                   /note="E3 ubiquitin-protein ligase rififylin"
FT                   /id="PRO_0000056027"
FT   DOMAIN          101..120
FT                   /note="SAP 1"
FT   DOMAIN          249..263
FT                   /note="SAP 2"
FT   ZN_FING         41..93
FT                   /note="FYVE-type"
FT   ZN_FING         315..350
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          17..37
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          162..183
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        20..37
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         228
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZQM0"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         196..223
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_015757"
SQ   SEQUENCE   362 AA;  40409 MW;  A410851306F48AD9 CRC64;
     MWASCCNWFC LDGQPEETPP PQGARTQAYS NPGYSSFPSP TGSEPSCKAC GVHFASTTRK
     QTCLDCKKNF CMTCSSQEGN GPRLCLLCLR FRATAFQREE LMKMKVKDLR DYLSLHDIST
     EMCREKEELV FLVLGQQPVI SEADRTRAPT LPQAFPEQQA FLTQPQSSTV PPTSPGLPSS
     PAQVTSVLAQ DQETQQAIGH VSQDHEEPIF LESTARVPPE DETQSVDSED SFVPGRRASL
     SDLTHLEDIE GLTVRQLKEI LARNFVNYKG CCEKWELMER VTRLYKDQKG LQHLVSGNED
     QNGGAVPSGL EENLCKICMD SPIDCVLLEC GHMVTCTKCG KRMNECPICR QYVIRAVHVF
     RS
//
